ERBB2 and breast carcinoma: However, no significant difference in [18F]FDG signal in the lung was observed between LM2-4 and LM2-4H2N, indicating that the artificially constructed LM2-4H2N cell line does not represent the metastatic spread observed HER2+ breast cancer in humans.